DOD Biotech PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	121.7	223.09	67.99	30.27	161.68	143
Short-Term Investments	131.96	-	-	-	-	-
Cash & Short-Term Investments	253.66	223.09	67.99	30.27	161.68	143
Cash Growth	79.68%	228.12%	124.62%	-81.28%	13.06%	73.51%
Accounts Receivable	53.59	24.37	82.29	39.05	315.37	263.19
Other Receivables	19.72	17.74	29.26	17.69	22.07	8.19
Receivables	73.3	42.1	111.55	56.74	337.44	271.38
Inventory	100.73	126.88	150.4	98.03	113.46	246.33
Other Current Assets	32.38	224.48	42.01	12.09	13.42	12.71
Total Current Assets	460.07	616.55	371.96	197.13	626	673.42
Property, Plant & Equipment	510.03	511.33	915.83	963	961.03	875.76
Long-Term Investments	2.6	2.6	2.6	2.6	2.6	105.71
Goodwill	0.25	0.25	0.25	-	-	-
Other Intangible Assets	38.45	43.06	50.48	5.57	5.66	11.44
Long-Term Deferred Tax Assets	81.94	95.5	90.64	92.54	7.9	26.53
Other Long-Term Assets	17	17.02	25.89	30.08	23.8	64.72
Total Assets	1,110	1,286	1,458	1,291	1,627	1,758
Accounts Payable	72.34	39.23	75.4	80.44	93.09	181.14
Accrued Expenses	-	22.5	25.25	17.17	13.64	31.9
Short-Term Debt	-	45	110.49	148.7	77	130.39
Current Portion of Long-Term Debt	6.92	-	2.12	19.81	28.76	39.58
Current Portion of Leases	0.48	0.77	2.8	2.62	4.92	8.34
Current Income Taxes Payable	2.07	1.72	21.18	1.66	-	25.32
Current Unearned Revenue	21.7	-	-	-	-	-
Other Current Liabilities	1.45	256.76	45.55	33.71	41.74	51.83
Total Current Liabilities	104.97	365.98	282.8	304.11	259.16	468.5
Long-Term Debt	37.77	-	-	2.12	19.31	22.28
Long-Term Leases	-	0.29	53.29	55.82	53.31	4.56
Pension & Post-Retirement Benefits	12.85	10.59	10.72	7.68	5.37	5.05
Long-Term Deferred Tax Liabilities	7.11	10.95	18.49	10.68	12.05	24.1
Other Long-Term Liabilities	6.53	6.6	12.29	16.87	15.5	8.17
Total Liabilities	169.23	394.4	377.58	397.29	364.7	532.66
Common Stock	225.21	225.21	225.21	205	205	205
Additional Paid-In Capital	651.33	947.27	1,051	890.85	890.85	939.87
Retained Earnings	68.87	-273.87	-225.16	-233.86	164.47	50.97
Comprehensive Income & Other	-	-	7.35	25.17	20.24	18.22
Total Common Equity	945.41	898.6	1,058	887.15	1,281	1,214
Minority Interest	-4.3	-6.69	22.12	6.48	-18.26	10.87
Shareholders' Equity	941.11	891.91	1,080	893.63	1,262	1,225
Total Liabilities & Equity	1,110	1,286	1,458	1,291	1,627	1,758
Total Debt	45.17	46.06	168.69	229.08	183.3	205.15
Net Cash (Debt)	208.49	177.03	-100.7	-198.81	-21.62	-62.15
Net Cash Growth	172.79%	-	-	-	-	-
Net Cash Per Share	0.46	0.39	-0.23	-0.48	-0.05	-0.15
Filing Date Shares Outstanding	450.41	450.41	450.41	410	410	410
Total Common Shares Outstanding	450.41	450.41	450.41	410	410	410
Working Capital	355.1	250.58	89.16	-106.98	366.85	204.93
Book Value Per Share	2.10	2.00	2.35	2.16	3.12	2.96
Tangible Book Value	906.71	855.29	1,007	881.58	1,275	1,203
Tangible Book Value Per Share	2.01	1.90	2.24	2.15	3.11	2.93
Land	-	153.48	218.87	218.87	218.87	220.57
Buildings	-	330.42	629.76	535.29	482.56	500.3
Machinery	-	199.85	297.4	275.58	228.29	272.82
Construction In Progress	-	26.62	13.71	109.92	159.25	22.27

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.